Peer Review reports
From: Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer
| Original Submission | ||
|---|---|---|
| 2 Nov 2023 | Submitted | Original manuscript |
| 13 Nov 2023 | Reviewed | Reviewer Report |
| 28 Nov 2023 | Reviewed | Reviewer Report |
| 23 Dec 2023 | Author responded | Author comments - Jacob Adashek |
| Resubmission - Version 2 | ||
| 23 Dec 2023 | Submitted | Manuscript version 2 |
| 2 Jan 2024 | Reviewed | Reviewer Report |
| 1 Feb 2024 | Author responded | Author comments - Jacob Adashek |
| Resubmission - Version 3 | ||
| 1 Feb 2024 | Submitted | Manuscript version 3 |
| Publishing | ||
| 12 Feb 2024 | Editorially accepted | |
| 19 Feb 2024 | Article published | 10.1186/s12916-024-03293-3 |
You can find further information about peer review here.